Researchers at the University of Maryland identified a potential link between early-onset ischemic stroke and a genetic ...

On February 27, 2025, the Emergency Department team at Mercer Health was recognized by the Ohio State University Wexner ...

New research shows that stress may increase the risk of stroke in younger women. Experts explain the stress-stroke connection ...

For patients with acute ischemic stroke whose symptoms began 4.5 to 24 hours earlier, alteplase is associated with a higher percentage of patients achieving a score of 0 or 1 on the modified Rankin ...

TNKase — tenecteplase — is the first FDA-approved stroke medicine in nearly 30 years, offering a faster, simpler five-second ...

Endovascular thrombectomy does not lead to better outcomes at 90 days compared with usual care or best medical treatment for patients with acute ischemic stroke due to medium vessel occlusion.

It is delivered as a single five-second intravenous bolus, which is faster than the standard of care Activase or alteplase, ...

The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

A new study found that moderate stress levels were associated with a 78% increased risk of stroke in female participants, but ...

A study has uncovered that iron orchestrates the activation of two damaging cell death pathways—ferroptosis and ...